AstraZeneca PLC is 226.8x more valuable than MapLight Therapeutics, Inc. by market capitalization ($286.27 B vs $1.26 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | MPLT | AZN |
|---|---|---|
| Market cap | $1.26 B | $286.27 B |
| US-listed rank | #2465 | #45 |
| Net income (latest FY) | -$161.15M | - |
| SEC filings | 144 | 1,004 |
AstraZeneca PLC is 226.8x more valuable than MapLight Therapeutics, Inc. by market capitalization ($286.27 B vs $1.26 B).
Full pages: MapLight Therapeutics, Inc. and AstraZeneca PLC, or browse the full rankings.